# Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age

> **NCT00441259** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 96 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** ChimeriVax™-JE
- **BIOLOGICAL:** Japanese Encephalitis Inactivated Mouse Brain Vaccine

## Key facts

- **NCT ID:** NCT00441259
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2011-02
- **Final completion:** 2011-12
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2012-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00441259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00441259, "Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00441259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*